Clinical Trials Logo

Clinical Trial Summary

Objective: The aim of this study is to assess the effects of raloxifene HCl on coagulation parameters in healthy postmenopausal women.

Material and method: 80 healthy postmenopausal women were evaluated at Karadeniz Technical University Hospital at gynecology out-patient clinic from December 2005 to December 2006. Local institutional ethics committee approved our study protocol and written informed consent was obtained from all participants before enrollment. All patients received daily 600 milligrams of calcium and 400 international units of vitamin D (Cal-D-VÄ°TA, Roche Switzerland,). 60 milligrams of raloxifene HCI, which is a selective estrogen receptor modulator (SERM), was added to treatment protocol if patients required hormonal therapy. Patients receiving raloxifene therapy in addition to calcium and vitamin D therapy formed the study group(n=50). Control group (n=30) was made up of the patients only receiving calcium and vitamin D. Factor 8, von Willebrand factor, protein C, protein S, antithrombin- III and fibrinogen levels were measured in all patients before treatment. These measurements were repeated at three and twelve months after treatment. Comparisons were performed with Student t test or Mann Whitney test between the two groups and two-way ANOVA within the groups. Proportions were compared with Fisher exact or Chi-square tests. Statistically analysis was done with SPSS packet program (SPSS 11; SPSS Inc.) All p values were two-tailed and p<0.05 was considered statistically significant.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04454775
Study type Observational [Patient Registry]
Source Karadeniz Technical University
Contact
Status Completed
Phase
Start date December 1, 2005
Completion date December 20, 2006

See also
  Status Clinical Trial Phase
Terminated NCT00932152 - Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer Phase 2
Completed NCT01740076 - Soy Nuts and Cardiovascular Risk in Postmenopausal Women N/A
Completed NCT03380000 - Effect of Beetroot Juice on Blood Pressure Regulation in Post Menopausal Women Phase 2
Recruiting NCT01259661 - Physical Activity and Metabolic Risk Factors in Postmenopausal Women N/A
Completed NCT00763464 - Coronary Artery Disease (CAD) in Postmenopausal Women N/A
Completed NCT00745108 - Tibolone Endometrium Study (Study 32972)(P06470) Phase 3
Completed NCT03644472 - Postmenopausal Women and Their Endothelium Phase 2
Terminated NCT05627791 - Effects of Vaginal Oxytocin Gel on Vaginal Cytologic Parameters in Postmenopausal Woman Phase 2/Phase 3
Recruiting NCT01472393 - Creatine on Bone Mass in Postmenopausal Women N/A
Recruiting NCT05964673 - Effect of Bioptron Light Therapy on Dryness of Eyes in Postmenopausal Women N/A
Completed NCT04762095 - The Effect of Mindfulness Stress Reduction Program on Menopausal Complaints and Quality of Life N/A
Recruiting NCT01376934 - Clinical Trial of Hysteroscopy in Postmenopausal Women to Compare Techniques N/A
Recruiting NCT03705845 - Tocotrienols for Obesity of Postmenopausal Women Phase 1/Phase 2
Completed NCT03940924 - HIIT + RT on Body Composition and Gut Microbiota in Postmenopausal Women (PACWOMan) N/A
Completed NCT00065546 - Human Requirements for the Nutrient Choline N/A
Completed NCT03191513 - The Acute Effects of Interesterification of Commercially Used Fats on Postprandial Fat Metabolism N/A
Completed NCT03492983 - Effect of High Cocoa Content Chocolate on Health in Postmenopausal Women. N/A
Recruiting NCT06042673 - Impact of Pomegranate Seed Oil on Postprandial Cardiovascular Disease Risk Markers N/A
Completed NCT00577720 - Assess the Safety, Efficacy, and Pharmacokinetics of Immediate and Delayed Release Weekly Risedronate Phase 2
Completed NCT02094144 - Health Benefits of a 6-month Brisk Walking Program in Sedentary Postmenopausal Women N/A